Corvus Pharmaceuticals, Inc. Patent Applications Pending
53 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2026-03-17: Application 19569194; Invention COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE; Applicant Corvus Pharmaceuticals, Inc.; Status Docketed New Case - Ready for Examination.
- 2025-06-23: Application 19142365; Invention METHODS FOR TREATING RENAL CELL CARCINOMA; Applicant Corvus Pharmaceuticals, Inc.; Status Docketed New Case - Ready for Examination.
- 2025-04-17: Application PCTUS2025025090; Invention ADENOSINE A2A RECEPTOR ANTAGONISTS TO TREAT REM SLEEP BEHAVIOR DISORDER AND PREVENT SYNUCLEINOPATHIES; Applicant CORVUS PHARMACEUTICALS, INC.; Status PCT - International Search Report Mailed to IB.
- 2025-02-05: Application PCTUS2025014628; Invention ITK INHIBITORS AND USES THEREOF; Applicant CORVUS PHARMACEUTICALS, INC.; Status PCT - International Search Report Mailed to IB.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 19569194 | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE | Corvus Pharmaceuticals, Inc. | Docketed New Case - Ready for Examination | US20260209216A1 | Ryan Hudson Anne- Marie Beausoleil | United States United States | CENTRAL, DOCKET |
| 2025-06-23 | 19142365 | METHODS FOR TREATING RENAL CELL CARCINOMA | Corvus Pharmaceuticals, Inc. | Docketed New Case - Ready for Examination | US20260217827A1 | Richard A. Miller Lih-Yun Hsu | United States United States | CENTRAL, DOCKET |
| 2025-04-17 | PCTUS2025025090 | ADENOSINE A2A RECEPTOR ANTAGONISTS TO TREAT REM SLEEP BEHAVIOR DISORDER AND PREVENT SYNUCLEINOPATHIES | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | RICHARD A. MILLER | United States | KIM, HARRY CHONG HYUN | |
| 2025-02-05 | PCTUS2025014628 | ITK INHIBITORS AND USES THEREOF | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | ERIK VERNER RICHARD A. MILLER LIH-YUN HSU WILLIAM B. JONES | United States United States United States United States | KIM, HARRY CHONG HYUN | |
| 2024-12-18 | PCTUS2024060702 | USE OF ITK INHIBITORS AND CAR T-CELL THERAPY | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | RICHARD A. MILLER LIH-YUN HSU | United States United States | KIM, HARRY CHONG HYUN | |
| 2024-10-21 | PCTUS2024052200 | INTERLEUKIN-2-INDUCIBLE T-CELL KINASE INHIBITORS TO PRODUCE ENHANCED IMMUNE RESPONSES | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | RICHARD A. MILLER LIH-YUN HSU | United States United States | KIM, HARRY CHONG HYUN | |
| 2024-09-30 | 18852735 | ITK INHIBITORS FOR INCREASING TH1 CELL ACTIVITY | Corvus Pharmaceuticals, Inc. | Docketed New Case - Ready for Examination | US20250213587A1 | Richard A. Miller Lih-Yun Hsu | United States United States | WHITE, DAWANNA SHAR-DAY |
| 2024-04-17 | 63635259 | ADENOSINE A2A RECEPTOR ANTAGONISTS TO TREAT REM SLEEP BEHAVIOR DISORDER AND PREVENT SYNUCLEINOPATHIES | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Richard A. Miller | United States | ||
| 2024-02-06 | 63550378 | ITK INHIBITORS AND USES THEREOF | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Erik Verner Richard A. Miller Lih-Yun Hsu William B. Jones | United States United States United States United States | ||
| 2023-12-26 | PCTUS2023085895 | METHODS FOR TREATING RENAL CELL CARCINOMA | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | RICHARD A. MILLER LIH-YUN HSU | United States United States | THOMAS, SHANE M | |
| 2023-12-18 | 63611539 | USE OF ITK INHIBITORS AND CAR T-CELL THERAPY | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Richard A. Miller Lih-Yun Hsu | United States United States | ||
| 2023-11-02 | 18289261 | ANTI-CD73 COMPOUNDS TO TREAT ONCOVIRUS-POSITIVE CANCERS | Corvus Pharmaceuticals, Inc. | Non Final Action Mailed | US20240301082A1 | Richard A. Miller Craig Hill | United States United States | MIDDLETON, DANAYA L |
| 2023-10-20 | 63545003 | INTERLEUKIN-2-INDUCIBLE T-CELL KINASE INHIBITORS TO PRODUCE ENHANCED IMMUNE RESPONSES | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Richard A. Miller Lih-Yun Hsu | United States United States | ||
| 2023-04-04 | PCTUS2023017376 | ITK INHIBITORS FOR INCREASING TH1 CELL ACTIVITY | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | RICHARD A. MILLER | United States | KIM, HARRY CHONG HYUN | |
| 2022-12-27 | 63477256 | METHODS FOR TREATING RENAL CELL CARCINOMA | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Richard A. Miller Lih-Yun Hsu | United States United States | ||
| 2022-10-21 | 63418158 | ITK INHIBITORS FOR INCREASING TH1 CELL ACTIVITY | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Richard A. Miller | United States | ||
| 2022-05-02 | PCTUS2022027291 | ANTI-CD73 COMPOUNDS TO TREAT ONCOVIRUS-POSITIVE CANCERS | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | RICHARD A. MILLER CRAIG HILL | United States United States | KIM, HARRY CHONG HYUN | |
| 2022-04-05 | 63327563 | ITK INHIBITORS FOR INCREASING TH1 CELL ACTIVITY | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Richard A. Miller | United States | ||
| 2021-05-05 | 63184660 | ANTI-CD73 COMPOUNDS TO TREAT ONCOVIRUS-POSITIVE CANCERS | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Richard A. Miller Craig Hill | United States United States | ||
| 2020-11-02 | PCTUS2020058555 | IMMUNOMODULATORY ANTI-CD73 ANTIBODIES AND USES THEREOF | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | RICHARD A. MILLER STEPHEN WILLINGHAM ANDREW HOTSON | United States United States United States | YOUNG, LEE W | |
| 2020-09-15 | 63078792 | ANTI-CD73 ANTIBODIES TO TREAT CORONAVIRUS | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Richard A. Miller | United States | ||
| 2020-04-22 | 63014015 | ANTI-CD73 ANTIBODIES TO TREAT CORONAVIRUS | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Richard A. Miller | United States | ||
| 2019-11-05 | PCTUS2019059933 | B-CELL ACTIVATING CD73 ANTIBODIES | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | JOSEPH BUGGY EMILY PICCIONE GRIFFIN ANDREW HOTSON | United States United States United States | YOUNG, LEE W | |
| 2019-11-01 | 62929650 | Immunomodulatory Anti-CD73 Antibodies and Uses Thereof | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Andrew Hotson Stephen Willingham Richard A. Miller | United States United States United States | ||
| 2019-09-20 | PCTUS2019052165 | PROCESSES FOR MAKING TRIAZOLO [4,5D] PYRAMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | KOLBOT BY BRADLEY HAMILTON WOLFE WILLIAM BENTON JONES | United States United States United States | THOMAS, SHANE M | |
| 2019-07-12 | PCTUS2019041695 | METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY ACTIVATION | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | ANDREW HOTSON RICHARD A. MILLER STEPHEN WILLINGHAM | United States United States United States | THOMAS, SHANE M | |
| 2019-07-12 | PCTUS2019041682 | METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY ACTIVATION | CORVUS PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | RICHARD A. MILLER ANDREW HOTSON STEPHEN WILLINGHAM | United States United States United States | THOMAS, SHANE M | |
| 2019-05-31 | 62855601 | B-CELL ACTIVATING CD73 ANTIBODIES | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Emily Piccione Joseph Buggy Andrew Hotson | United States United States United States | ||
| 2019-05-15 | 62848524 | B-CELL ACTIVATING CD73 ANTIBODIES | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Emily Piccione Joseph Buggy Andrew Hotson | United States United States United States | ||
| 2019-05-10 | 62846525 | METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY ACTIVATION | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Stephen Willingham Andrew Hotson Richard A. Miller | United States United States United States | ||
| 2019-05-10 | 62846524 | METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY ACTIVATION | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Stephen Willingham Andrew Hotson Richard A. Miller | United States United States United States | ||
| 2019-02-01 | PCTUS2019016284 | PHARMACEUTICAL FORMULATIONS | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | BRET BERNER WILLIAM JONES JINGRONG XU FELICIA FLICKER | United States United States United States United States | THOMAS, SHANE M | |
| 2018-11-08 | 62757630 | COMBINED ADENOSINE RECEPTOR INHIBITOR-ATEZOLIZUMAB TREATMENT FOR CANCER | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Stephen Willingham Andrew Hotson Richard A. Miller | United States United States United States | ||
| 2018-11-08 | 62757623 | METHODS FOR DETECTING ADENOSINE PATHWAY ACTIVATION | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Stephen Willingham Andrew Hotson Richard A. Miller | United States United States United States | ||
| 2018-11-06 | PCTUS2018059481 | COMBINATION THERAPY FOR CANCER TREATMENT | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | RICHARD A. MILLER IAN MCCAFFERY ANDREW HOTSON | United States United States United States | THOMAS, SHANE M | |
| 2018-11-06 | PCTUS2018059480 | ADENOSINE PATHWAY INHIBITORS FOR CANCER TREATMENT | CORVUS PHARMACEUTICALS INC. | PCT - International Search Report Mailed to IB | ANDREW HOTSON RICHARD A. MILLER IAN MCCAFFERY | United States United States United States | THOMAS, SHANE M | |
| 2018-11-05 | 62756065 | B-Cell Activating CD73 Antibody | Corvus Pharmaceuticals, Inc | Provisional Application Expired | Emily Piccione Joseph Buggy Andrew Hotson | United States United States United States | ||
| 2018-10-08 | 62742919 | COMBINED ADENOSINE RECEPTOR INHIBITOR-ATEZOLIZUMAB TREATMENT FOR CANCER | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Stephen Willingham Andrew Hotson Richard A. Miller | United States United States United States | ||
| 2018-10-08 | 62742912 | METHODS FOR DETECTING ADENOSINE PATHWAY ACTIVATION | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Stephen Willingham Andrew Hotson Richard A. Miller | United States United States United States | ||
| 2018-09-27 | 62737839 | PROCESSES FOR MAKING TRIAZOLO[4,5D] PYRAMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Kolbot By William Benton Jones Bradley Hamilton Wolfe | United States United States United States | ||
| 2018-08-31 | PCTUS2018049206 | COMPOUNDS AND METHODS FOR MODULATING ADENOLSINE A28 RECEPTOR AND ADENOSINE A2A RECEPTOR | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | LUBOV KONSTANTINOVNA FILONOVA ZHIHONG LI ERIK VERNER ERIN KATHLEEN BRADLEY | United States United States United States United States | THOMAS, SHANE M | |
| 2018-08-31 | 62725621 | COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Zhihong Li Lubov Konstantinovna Filonova Erik Verner | United States United States United States | ||
| 2018-04-04 | PCTUS2018026142 | METHODS FOR TREATING CD73HI TUMORS | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | IAN MCCAFFERY EMILY PICCIONE GRIFFIN | United States United States | YOUNG, LEE W | |
| 2018-04-04 | PCTUS2018026138 | METHODS OF TREATING CANCER | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | IAN MCCAFFERY STEPHEN WILLINGHAM | United States United States | YOUNG, LEE W | |
| 2018-03-30 | PCTUS2018025574 | PROCESSES FOR MAKING TRIAZOLO[4,5D] PYRAMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | KOLBOT BY BRADLEY HAMILTON WOLFE WILLIAM BENTON JONES | United States United States United States | YOUNG, LEE W | |
| 2017-11-03 | PCTUS2017059871 | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | ANNE-MARIE BEAUSOLEIL RYAN HUDSON | United States United States | YOUNG, LEE W | |
| 2017-07-11 | PCTUS2017041598 | ANTI-CD73 ANTIBODIES | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | EMILY PICCIONE GRIFFIN RICHARD A. MILLER IAN MCCAFFRERY | United States United States United States | THOMAS, SHANE M | |
| 2017-03-30 | 62479235 | PROCESSES FOR MAKING TRIAZOLO[4,5D] PYRAMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | Corvus Pharmaceuticals, Inc. | Provisional Application Expired | Kolbot By William Benton Jones Bradley Hamilton Wolfe | United States United States United States | ||
| 2017-03-10 | PCTUS2017021966 | COMPOUNDS AND METHODS FOR MODULATING BRUTON'S TYROSINE KINASE | CORVUS PHARMACEUTICALS, INC. | PCT - International Search Report Mailed to IB | RYAN HUDSON ERIK VERNER RICHARD A. MILLER ANNE-MARIE BEAUSOLEIL | United States United States United States United Kingdom | THOMAS, SHANE M | |
| 2016-12-22 | PCTUS2016068459 | METHODS OF TREATING CANCER | CORVUS PHARMACEUTICALS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | ANDREW HOTSON lAN MCCAFFRY STEPHEN WILLINGHAM RICHARD A. MILLER PO Y. HO | United States United States United States United States United States | YOUNG, LEE W | |
| 19610145 | ITK INHIBITORS AND USES THEREOF | CORVUS PHARMACEUTICALS, INC. | Application Undergoing Preexam Processing | Erik Verner Richard A. Miller Lih-Yun Hsu William B. Jones | United States United States United States United States | |||
| 19595394 | USE OF ITK INHIBITORS AND CAR T-CELL THERAPY | Corvus Pharmaceuticals, Inc. | Application Undergoing Preexam Processing | Richard A. Miller Lih-Yun Hsu | United States United States | |||
| 19528624 | INTERLEUKIN-2-INDUCIBLE T-CELL KINASE INHIBITORS TO PRODUCE ENHANCED IMMUNE RESPONSES | Corvus Pharmaceuticals, Inc. | Application Undergoing Preexam Processing | Richard A. Miller Lih-Yun Hsu | United States United States |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |